302 results on '"Fujimori, Juichi"'
Search Results
2. Stochastic models for the onset and disease course of multiple sclerosis
3. Brain volume loss in Japanese patients with multiple sclerosis is present in the early to middle stage of the disease
4. Early-stage volume losses in the corpus callosum and thalamus predict the progression of brain atrophy in patients with multiple sclerosis
5. White blood cell count profiles in anti-aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder and anti-myelin oligodendrocyte glycoprotein antibody-associated disease
6. Health-related quality of life in Japanese patients with multiple sclerosis
7. Associations between neuromyelitis optica spectrum disorder, Sjögren's syndrome, and conditions with electrolyte disturbances
8. Relapse activity in the chronic phase of anti-myelin-oligodendrocyte glycoprotein antibody-associated disease
9. Slowly expanding lesions are associated with disease activity and gray matter loss in relapse‐onset multiple sclerosis.
10. Two-dimensional measurements with cut-off values are useful for assessing brain volume, physical disability, and processing speed in multiple sclerosis
11. Correlation of the symbol digit modalities test with the quality of life and depression in Japanese patients with multiple sclerosis
12. Five-year visual outcomes after optic neuritis in anti-MOG antibody-associated disease
13. Progression pattern of neurological disability with respect to clinical attacks in anti-MOG antibody-associated disorders
14. Assisting the diagnosis of multiple sclerosis using a set of regional brain volumes: A classification model for patients and healthy controls
15. Impact of comorbid Sjögren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders
16. Seasonal variation of onset in patients with anti-aquaporin-4 antibodies and anti-myelin oligodendrocyte glycoprotein antibody
17. Measurements of the corpus callosum index and fractional anisotropy of the corpus callosum and their cutoff values are useful to assess global brain volume loss in multiple sclerosis
18. Impact of intrathecal IgG synthesis on neurological disability in patients with multiple sclerosis
19. Basal Ganglia Atrophy and Impaired Cognitive Processing Speed in Multiple Sclerosis
20. Enlarged choroid plexus in multiple sclerosis is associated with increased lesion load and atrophy in white matter but not gray matter atrophy
21. Patterns of regional brain volume loss in multiple sclerosis: a cluster analysis
22. White blood cell count profiles in multiple sclerosis during attacks before the initiation of acute and chronic treatments
23. Myelin oligodendrocyte glycoprotein antibody‐associated disorders: An overview
24. CSF CXCL13 is elevated in patients with CIDP and may reflect higher disease activity
25. Characterization of Japanese multiple sclerosis patients with progression independent of relapse activity: A 2-year multicenter cohort study
26. Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders
27. Myelin oligodendrocyte glycoprotein antibody‐associated disorders: An overview.
28. Myelin oligodendrocyte glycoprotein antibody-associated disease in a patient with symptoms of aseptic meningitis who achieved spontaneous remission: A case report and review of the literature
29. Clinical features and biomarkers of acute encephalitis with claustrum sign (P5-5.027)
30. Epidemiological and clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in a nationwide survey
31. Early-stage volume losses in the corpus callosum and thalamus predict the progression of brain atrophy in patients with multiple sclerosis
32. Ictal chest discomfort in a patient with temporal lobe seizures and amygdala enlargement
33. sj-pptx-5-msj-10.1177_13524585231156736 – Supplemental material for Epidemiological and clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in a nationwide survey
34. sj-docx-12-msj-10.1177_13524585231156736 – Supplemental material for Epidemiological and clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in a nationwide survey
35. sj-pptx-2-msj-10.1177_13524585231156736 – Supplemental material for Epidemiological and clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in a nationwide survey
36. sj-docx-9-msj-10.1177_13524585231156736 – Supplemental material for Epidemiological and clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in a nationwide survey
37. sj-docx-6-msj-10.1177_13524585231156736 – Supplemental material for Epidemiological and clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in a nationwide survey
38. sj-pptx-3-msj-10.1177_13524585231156736 – Supplemental material for Epidemiological and clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in a nationwide survey
39. sj-docx-8-msj-10.1177_13524585231156736 – Supplemental material for Epidemiological and clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in a nationwide survey
40. sj-pptx-1-msj-10.1177_13524585231156736 – Supplemental material for Epidemiological and clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in a nationwide survey
41. sj-docx-7-msj-10.1177_13524585231156736 – Supplemental material for Epidemiological and clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in a nationwide survey
42. Health-related quality of life in Japanese patients with multiple sclerosis
43. Cerebrospinal fluid CXCL13 is a prognostic marker for aseptic meningitis
44. Follow-up of retinal thickness and optic MRI after optic neuritis in anti-MOG antibody-associated disease and anti-AQP4 antibody-positive NMOSD
45. sj-docx-1-mso-10.1177_20552173211070749 - Supplemental material for Usefulness of two-dimensional measurements for the evaluation of brain volume and disability in multiple sclerosis
46. sj-doc-2-mso-10.1177_20552173211070749 - Supplemental material for Usefulness of two-dimensional measurements for the evaluation of brain volume and disability in multiple sclerosis
47. Decreased subcortical T2 FLAIR signal with cortical T2 FLAIR hyperintense lesions in unilateral cerebral cortical encephalitis with myelin oligodendrocyte glycoprotein antibody
48. Usefulness of two-dimensional measurements for the evaluation of brain volume and disability in multiple sclerosis
49. Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
50. Serum neurofilament light is a sensitive biomarker that reflects grey matter volume in Japanese patients with multiple sclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.